Yingqing Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yingqing Lu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- R. Michael van Dam
Crump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA
6 shared publications - Jason Jones
Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA),Los Angeles, CA, USA
2 shared publications Viviann Do
Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA),Los Angeles, CA, USA
2 shared publicationsAlejandra Rios
Physics and Biology in Medicine Interdepartmental Graduate Program, UCLA, Los Angeles, CA, USA; Crump Institute for Molecular Imaging, UCLA, Los Angeles, CA, USA
1 shared publicationChelsea C. Okoro
Institute for Society and Genetics, UCLA, Los Angeles, CA, USA; Crump Institute for Molecular Imaging, UCLA, Los Angeles, CA, USA
1 shared publicationJeffrey Collins
Crump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA, USA
1 shared publication
Latest Publications
- Open Access
- 24 October 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1363
Efficient Copper-Mediated Radiosynthesis of 6-[18F]Fluoro-L-DOPA ([18F]FDOPA) in a Microreactor
Objectives: The diagnostic radiopharmaceutical 6-[18F]Fluoro-L-DOPA ([18F]FDOPA) is a versatile positron emission tomography (PET) tracer used to image dopaminergic dysfunction in Parkinson’s disease, brain tumors, and neuroendocrine disorders. Despite its broad clinical applications, [18F]FDOPA production remains challenging. The electron-rich aromatic structure has traditionally necessitated electrophilic [18F]F2 labeling, resulting in low molar activity and potentially increasing the risk of pharmacological effects. Copper-mediated radiofluorination of organoboron precursors using nucleophilic [18F]fluoride provides a promising alternative but remains constrained by lengthy preparation time and high precursor consumption. Here, we developed a microscale copper-mediated radiosynthesis of [18F]FDOPA using a chip-based microreactor. Methods: A comprehensive set of reaction parameters, including type and amount of phase-transfer catalyst and base, solvent and additive composition, precursor and copper reagent quantity, concentration of deprotectant, and reaction temperature and time, was systematically evaluated using high-throughput microscale experiments. The optimized protocol was performed in a 10 μL reaction volume, followed by deprotection and purification using analytical radio-high-performance liquid chromatography (HPLC). Results: Starting from 0.03–1.54 GBq of [18F]fluoride, the optimized protocol afforded 0.02–0.83 GBq of [18F]FDOPA in a 25 min manually-operated synthesis (n = 16), corresponding to a radiochemical yield of 65 ± 2% and activity yield of 56 ± 2%. In contrast, a literature report of the conventionally-performed synthesis had a >4-fold longer preparation time and afforded 2.44 ± 0.70 GBq of product from 35–63 GBq starting activity, with an RCY of 10 ± 2% and activity yield of 5 ± 1%. Molar activity of the microscale synthesis was high (76–621 GBq μmol−1), and the product exhibited excellent radiochemical purity (>99%) and enantiomeric purity (100%). Conclusions: This microscale approach enables rapid, high-yield, and source-efficient production of [18F]FDOPA at quantities relevant for preclinical applications and supports further development toward future clinical translation.
- 24 October 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1363
Open AccessEfficient Copper-Mediated Radiosynthesis of 6-[18F]Fluoro-L-DOPA ([18F]FDOPA) in a Microreactor
Objectives: The diagnostic radiopharmaceutical 6-[18F]Fluoro-L-DOPA ([18F]FDOPA) is a versatile positron emission tomography (PET) tracer used to image dopaminergic dysfunction in Parkinson’s disease, brain tumors, and neuroendocrine disorders. Despite its broad clinical applications, [18F]FDOPA production remains challenging. The electron-rich aromatic structure has traditionally necessitated electrophilic [18F]F2 labeling, resulting in low molar activity and potentially increasing the risk of pharmacological effects. Copper-mediated radiofluorination of organoboron precursors using nucleophilic [18F]fluoride provides a promising alternative but remains constrained by lengthy preparation time and high precursor consumption. Here, we developed a microscale copper-mediated radiosynthesis of [18F]FDOPA using a chip-based microreactor. Methods: A comprehensive set of reaction parameters, including type and amount of phase-transfer catalyst and base, solvent and additive composition, precursor and copper reagent quantity, concentration of deprotectant, and reaction temperature and time, was systematically evaluated using high-throughput microscale experiments. The optimized protocol was performed in a 10 μL reaction volume, followed by deprotection and purification using analytical radio-high-performance liquid chromatography (HPLC). Results: Starting from 0.03–1.54 GBq of [18F]fluoride, the optimized protocol afforded 0.02–0.83 GBq of [18F]FDOPA in a 25 min manually-operated synthesis (n = 16), corresponding to a radiochemical yield of 65 ± 2% and activity yield of 56 ± 2%. In contrast, a literature report of the conventionally-performed synthesis had a >4-fold longer preparation time and afforded 2.44 ± 0.70 GBq of product from 35–63 GBq starting activity, with an RCY of 10 ± 2% and activity yield of 5 ± 1%. Molar activity of the microscale synthesis was high (76–621 GBq μmol−1), and the product exhibited excellent radiochemical purity (>99%) and enantiomeric purity (100%). Conclusions: This microscale approach enables rapid, high-yield, and source-efficient production of [18F]FDOPA at quantities relevant for preclinical applications and supports further development toward future clinical translation.
- Open Access
Rapid Concentration of Ga-68 and Proof-of-Concept Microscale Labeling of [68Ga]Ga-PSMA-11 in a Droplet Reactor
The radiometal gallium-68 (Ga-68) has garnered significant interest due to its convenient production via compact and widely available generators and the high performance of 68Ga-labeled compounds for positron-emission tomography (PET) imaging for cancer diagnosis and management of patients undergoing targeted radionuclide therapy. Given the short half life of Ga-68 (68 min), microfluidic-based radiosynthesis is a promising avenue to establish very rapid, efficient, and routine radiolabeling with Ga-68; however, the typical elution volume of Ga-68 from a generator (4–10 mL) is incompatible with the microliter reaction volumes of microfluidic devices. To bridge this gap, we developed a microscale cartridge-based approach to concentrate Ga-68. By optimizing cartridge design, resin type, resin mass, and eluent composition, Ga-68 was reliably concentrated from ~6 mL to ~80 µL with high recovery efficiency (>97%, n = 14). Furthermore, this method is suitable for both single- and dual-generator setups. To demonstrate suitability of the concentrated radiometal for radiolabeling, we performed microdroplet synthesis of [68Ga]Ga-PSMA-11, achieving high radiochemical yield (83 ± 11%, n = 3), excellent radiochemical purity (>99%), and high apparent specific activity (255–320 MBq/μg). The entire process, including Ga-68 concentration, radiosynthesis, purification, and formulation, was completed in 12 min. Starting with activity of 0.81–0.84 GBq, 0.51–0.64 GBq of product was produced, sufficient for multiple patient doses. This work paves the way to clinical-scale production of other 68Ga-labeled compounds using droplet microreactor methods, or high-throughput labeling optimization or compound screening of 68Ga-labeled probes using droplet reaction arrays.
Open AccessRapid Concentration of Ga-68 and Proof-of-Concept Microscale Labeling of [68Ga]Ga-PSMA-11 in a Droplet Reactor
The radiometal gallium-68 (Ga-68) has garnered significant interest due to its convenient production via compact and widely available generators and the high performance of 68Ga-labeled compounds for positron-emission tomography (PET) imaging for cancer diagnosis and management of patients undergoing targeted radionuclide therapy. Given the short half life of Ga-68 (68 min), microfluidic-based radiosynthesis is a promising avenue to establish very rapid, efficient, and routine radiolabeling with Ga-68; however, the typical elution volume of Ga-68 from a generator (4–10 mL) is incompatible with the microliter reaction volumes of microfluidic devices. To bridge this gap, we developed a microscale cartridge-based approach to concentrate Ga-68. By optimizing cartridge design, resin type, resin mass, and eluent composition, Ga-68 was reliably concentrated from ~6 mL to ~80 µL with high recovery efficiency (>97%, n = 14). Furthermore, this method is suitable for both single- and dual-generator setups. To demonstrate suitability of the concentrated radiometal for radiolabeling, we performed microdroplet synthesis of [68Ga]Ga-PSMA-11, achieving high radiochemical yield (83 ± 11%, n = 3), excellent radiochemical purity (>99%), and high apparent specific activity (255–320 MBq/μg). The entire process, including Ga-68 concentration, radiosynthesis, purification, and formulation, was completed in 12 min. Starting with activity of 0.81–0.84 GBq, 0.51–0.64 GBq of product was produced, sufficient for multiple patient doses. This work paves the way to clinical-scale production of other 68Ga-labeled compounds using droplet microreactor methods, or high-throughput labeling optimization or compound screening of 68Ga-labeled probes using droplet reaction arrays.
- 10 January 2024
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (4) , 728-737
Scalable droplet-based radiosynthesis of [ 18 F]fluorobenzyltriphenylphosphonium cation ([ 18 F]FBnTP) via a “numbering up” approach
Rapid, efficient and straightforward radiosynthesis scale-up strategy for droplet-based reactions via a numbering up technique.
- 10 January 2024
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (4) , 728-737
Scalable droplet-based radiosynthesis of [ 18 F]fluorobenzyltriphenylphosphonium cation ([ 18 F]FBnTP) via a “numbering up” approach
Rapid, efficient and straightforward radiosynthesis scale-up strategy for droplet-based reactions via a numbering up technique.
- 2 October 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (21) , 4652-4663
Proof-of-concept optimization of a copper-mediated 18 F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation
Copper-mediated radiofluorination has demonstrated remarkable potential in forming aromatic C–18F bonds of radioligands for positron emission tomography (PET). Achieving optimal results often requires optimization efforts, requiring a substantial amount of radiolabeling precursor and time, severely limiting the experimental throughput. Recently, we successfully showcased the feasibility of performing and optimizing Cu-mediated radiosynthesis on a high-throughput microdroplet platform using the well-known and clinically used radioligand [18F]FDOPA as an illustrative example. In our current work, we optimized the Cu-mediated synthesis of a novel monoacylglycerol lipase (MAGL) PET tracer ([18F]YH149), showing the versatility of droplet-based techniques for early stage tracer development. Across 5 days, we conducted a total of 117 experiments, studying 36 distinct conditions, while utilizing n = 5), the optimized droplet condition provided a substantial improvement in RCY (52 ± 8%, n = 4) and showed excellent radiochemical purity (100%) and molar activity (77–854 GBq μmol−1), using a starting activity of 0.2–1.45 GBq. Furthermore, we showed for the first time a translation of the optimized microscale conditions to a vial-based method. With similar starting activity (0.2–1.44 GBq), the translated synthesis exhibited a comparable RCY of 50 ± 10% (n = 4) while maintaining excellent radiochemical purity (100%) and acceptable molar activity (20–46 GBq μmol−1). The successful translation to vial-based reactions ensures wider applicability of the optimized synthesis by leveraging widely available commercial vial-based synthesis modules.
- 2 October 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (21) , 4652-4663
Proof-of-concept optimization of a copper-mediated 18 F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation
Copper-mediated radiofluorination has demonstrated remarkable potential in forming aromatic C–18F bonds of radioligands for positron emission tomography (PET). Achieving optimal results often requires optimization efforts, requiring a substantial amount of radiolabeling precursor and time, severely limiting the experimental throughput. Recently, we successfully showcased the feasibility of performing and optimizing Cu-mediated radiosynthesis on a high-throughput microdroplet platform using the well-known and clinically used radioligand [18F]FDOPA as an illustrative example. In our current work, we optimized the Cu-mediated synthesis of a novel monoacylglycerol lipase (MAGL) PET tracer ([18F]YH149), showing the versatility of droplet-based techniques for early stage tracer development. Across 5 days, we conducted a total of 117 experiments, studying 36 distinct conditions, while utilizing n = 5), the optimized droplet condition provided a substantial improvement in RCY (52 ± 8%, n = 4) and showed excellent radiochemical purity (100%) and molar activity (77–854 GBq μmol−1), using a starting activity of 0.2–1.45 GBq. Furthermore, we showed for the first time a translation of the optimized microscale conditions to a vial-based method. With similar starting activity (0.2–1.44 GBq), the translated synthesis exhibited a comparable RCY of 50 ± 10% (n = 4) while maintaining excellent radiochemical purity (100%) and acceptable molar activity (20–46 GBq μmol−1). The successful translation to vial-based reactions ensures wider applicability of the optimized synthesis by leveraging widely available commercial vial-based synthesis modules.
- Open Access
- 1 January 2023
- Published by Elsevier in SSRN Electronic Journal
Accelerating Radiochemistry Development: Automated Robotic Platform for Performing Up to 64 Droplet Radiochemical Reactions in a Morning
The growing discovery and development of novel radiopharmaceuticals and radiolabeling methods requires an increasing capacity for radiochemistry experiments. However, such studies typically rely on radiosynthesizers designed for clinical batch production rather than research, greatly limiting throughput. Two general solutions are being pursued to address this: developing new synthesis optimization algorithms to minimize how many experiments are needed, and developing apparatus with enhanced experiment throughput. We describe here a novel high-throughput system based on performing arrays of droplet-based reactions at 10 μL volume scale in parallel. The automatic robotic platform can perform a set of 64 experiments in ~3 h (from isotope loading to crude product, plus sampling onto TLC plates), plus ~1 h for off-line radio-TLC analysis and radioactivity measurements, rather than the weeks or months that would be needed using a conventional system. We show the high repeatability and low crosstalk of the platform and demonstrate optimization studies for two 18F-labeled tracers. This novel automated platform greatly increases the practicality of performing arrays of droplet reactions by eliminating human error, vastly reducing tedium and fatigue, minimizing radiation exposure, and freeing up radiochemist time for more intellectually valuable pursuits.
- 1 January 2023
- Published by Elsevier in SSRN Electronic Journal
Open AccessAccelerating Radiochemistry Development: Automated Robotic Platform for Performing Up to 64 Droplet Radiochemical Reactions in a Morning
The growing discovery and development of novel radiopharmaceuticals and radiolabeling methods requires an increasing capacity for radiochemistry experiments. However, such studies typically rely on radiosynthesizers designed for clinical batch production rather than research, greatly limiting throughput. Two general solutions are being pursued to address this: developing new synthesis optimization algorithms to minimize how many experiments are needed, and developing apparatus with enhanced experiment throughput. We describe here a novel high-throughput system based on performing arrays of droplet-based reactions at 10 μL volume scale in parallel. The automatic robotic platform can perform a set of 64 experiments in ~3 h (from isotope loading to crude product, plus sampling onto TLC plates), plus ~1 h for off-line radio-TLC analysis and radioactivity measurements, rather than the weeks or months that would be needed using a conventional system. We show the high repeatability and low crosstalk of the platform and demonstrate optimization studies for two 18F-labeled tracers. This novel automated platform greatly increases the practicality of performing arrays of droplet reactions by eliminating human error, vastly reducing tedium and fatigue, minimizing radiation exposure, and freeing up radiochemist time for more intellectually valuable pursuits.
- 21 November 2022
- Published by Elsevier in Journal of Chromatography A
- Vol. 1687, 463656
A rapid and systematic approach for the optimization of radio thin-layer chromatography resolution
- 21 November 2022
- Published by Elsevier in Journal of Chromatography A
- Vol. 1687, 463656
A rapid and systematic approach for the optimization of radio thin-layer chromatography resolution